RFO formulates binder improvement as a residue-wise mutational search problem, sampling candidate substitutions alternately based on gradient-guided sequence optimization using all-atom structure prediction models and a cycling-based sequence redesign strategy that alternates structure generation with an orthogonal predictor and MPNN-based sequence design.
Abstract
Biomolecular interactions, including protein–protein interactions, protein–nucleic acid recognition, and protein–small molecule binding, underlie a wide range of biological processes and therapeutic mechanisms. Although recent de novo design methods can generate candidate binders for diverse molecular targets, practical design campaigns remain limited by low filter-passing rates and model-specific biases that arise when designs are optimized against a single predictor. Here, we present RFOptimization (RFO), a training-free framework for all-atom biomolecular binder optimization. RFO formulates binder improvement as a residue-wise mutational search problem, sampling candidate substitutions alternately based on gradient-guided sequence optimization using all-atom structure prediction models and a cycling-based sequence redesign strategy that alternates structure generation with an orthogonal predictor and MPNN-based sequence design to improve the in silico success rate of RFdiffusion-generated binders within minutes of computation. To reduce overfitting to any individual structure model, candidate mutations are further evaluated with orthogonal AlphaFold3 metrics as final filters. We demonstrate the generality of RFO across diverse design settings, including classical protein binder design, ligand-binding biosensor design, cyclic peptide design, and active site-aware enzyme design.
NACraft, a training-free and programmatic framework for all-atom nucleic-acid aptamer design based on backpropagation through structure-model feedback, is presented, demonstrating the effectiveness and versatility of NACraft and extending structure-model hallucination toward programmatic nucleic-acid aptamer design.
Peptides are attractive molecular recognition elements because of their compact size, ease of modification, and structural tunability. The design of high-affinity peptides for small molecules lags far behind that of antibodies and aptamers due to the lack of general and effective discovery and optimization strategies....
Li-Hong Yu, Yun Ma, Yue-Hong Pang et al.· Analytical Chemistry· 0 citations
Testing the ability of common large language models to consider design principles to generate de novo proteins that bind metals and lipophilic small molecules without copying existing sequences highlights the utility of LLMs in making protein design more comprehensible and accessible to users without sophisticated desi...
Nam Hyeong Kim, A. K. Hatstat, Hyunil Jo et al.· bioRxiv· 0 citations
These results establish motif scaffolding of surface-complementing seeds as an effective strategy for overcoming current limitations of de novo generative models, enabling the design of proteins that can engage challenging interface sites.
D. Britton, Dia A. Ghose, J. Halpin et al.· bioRxiv· 0 citations
Built with VRH, VenusREM2 is the first to rank highest in all function, taxon, MSA-depth, and mutation-depth categories, with a ProteinGym Average Spearman of 0.556, 0.038 above the prior best.
Yang Tan, Qi-Jia Tian, Gang-Yu Sun et al.· 0 citations
The interaction between proteins and ligands is the core mechanism of biological activities and drug development. In traditional experimental methods, there are a series of problems such as long research cycles, high costs, and limited precision. In the rapid way of artificial intelligence (AI) era, AI tools have drive...
K. Tang· Theoretical and Natural Scie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.